Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!
01 7Evonik
02 1Faran Shimi Pharmaceutical
03 2Gangwal Healthcare
04 3Alcedo Pharmachem
05 21BASF
06 4Corel Pharma Chem
07 3Finar
08 2Gangwal Chemicals
09 1Huzhou Sunflower Pharmaceutical
10 5Ideal Cures Pvt Ltd
11 16Kerry
12 1Kima Chemical
13 1Lonza Capsugel
14 4Lubrizol Life Science Health
15 2Novo Excipients
16 2Pluviaendo
17 2The Dow Chemical Company
Application : Controlled & Modified Release, Solubilizers
Excipient Details : EUDRAGIT® L 100, a functional delayed release polymer is used to increase solubility of poorly soluble products such as tablets, capsules, ODTs, etc.
Pharmacopoeia Ref : NA
Technical Specs : Available as powder; Other grades- EUDRAGIT® L 12,5
Ingredient(s) : METHACRYLIC ACID COPOLYMER TYPE A
Ingredient(s) : METHACRYLIC ACID COPOLYMER TYPE A
Category : Controlled & Modified Release, Solubilizers
Brand : EUDRAGIT® L 100
Pharmacopoeia Ref : NA
Technical Specs : Available as powder; Other grades- EUDRAGIT® L 12,5
Grade : Oral
Dosage Form : Injectable / Parenteral
Grade : Parenteral
Brand Name : Potassium Chloride
Application : Parenteral
Excipient Details : Potassium chloride is used as a diuretic-osmotic in injectable and parenteral solutions.
Pharmacopoeia Ref : NA
Technical Specs : NA
Ingredient(s) : Potassium Chloride Excipient
Dosage Form : Injectable / Parenteral
Grade : Parenteral
Ingredient(s) : Potassium Chloride Excipient
Dosage Form : Injectable / Parenteral
Category : Parenteral
Brand : POTASSIUM CHLORIDE
Applications : Potassium chloride is used as a diuretic-osmotic in injectable and parenteral solutions.
Pharmacopoeia Ref : NA
Technical Specs : NA
Grade : Parenteral
Application : Co-Processed Excipients, Controlled & Modified Release, Direct Compression
Excipient Details : DiCOM-DC SR300 is used as a directly compressible, rate-controlling, and co-processed excipient in sustained-release tablets and capsules.
Pharmacopoeia Ref : In-house
Technical Specs : NA
Ingredient(s) : EthylCellulose, Hydroxypropyl Cellulose, Hydroxypropyl Methylcellulose, Magnesium Stearate, Maize Starch, Microcrystalline Cellulose, Silicon Dioxide, Talc
Brand : DICOM-DC® SR300
Pharmacopoeia Ref : In-house
Technical Specs : NA
Grade : Oral
Dosage Form : Capsule, Granule / Pellet, Tablet
Grade : Oral
Brand Name : EUDRAGIT® L 100-55
Application : Controlled & Modified Release, Solubilizers
Excipient Details : EUDRAGIT® L 100-55 polymer is used in delayed, sustained-release coatings to enhance solubility of poorly soluble drugs such as tablets, capsules, etc.
Pharmacopoeia Ref : NA
Technical Specs : Available as powder; Other grades- EUDRAGIT® L 30 D-55
Ingredient(s) : Methacrylic Acid - Ethyl Acrylate Copolymer
Dosage Form : Capsule, Granule / Pellet, Tablet
Grade : Oral
Ingredient(s) : Methacrylic Acid - Ethyl Acrylate Copolymer
Dosage Form : Capsule, Granule / Pellet, Tablet
Category : Controlled & Modified Release, Solubilizers
Brand : EUDRAGIT® L 100-55
Pharmacopoeia Ref : NA
Technical Specs : Available as powder; Other grades- EUDRAGIT® L 30 D-55
Grade : Oral
Application : Controlled & Modified Release, Solubilizers
Excipient Details : EUDRAGIT® RL, an insoluble, highly permeable polymer used in combination with EUDRAGIT® RS in customized release drugs such as tablets, capsules, etc.
Pharmacopoeia Ref : NA
Technical Specs : Other grades- EUDRAGIT® RL 12,5, EUDRAGIT® RL 30 D, EUDRAGIT® RL PO
Ingredient(s) : Ammonia Methacrylate Copolymer Type A
Ingredient(s) : Ammonia Methacrylate Copolymer Type A
Category : Controlled & Modified Release, Solubilizers
Brand : EUDRAGIT® RL 100
Pharmacopoeia Ref : NA
Technical Specs : Other grades- EUDRAGIT® RL 12,5, EUDRAGIT® RL 30 D, EUDRAGIT® RL PO
Grade : Oral